INOMAX EVOLVE

LIVE

Serial Number

97820856

Owner

Mallinckrodt Pharmaceuticals Ireland Limited

Attorney

Camille M. Miller

Filing Date

Mar 2, 2023

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

INOMAX EVOLVE Trademark

Serial Number: 97820856 • Registration: 8170063

INOMAX EVOLVE is a trademark filed by Mallinckrodt Pharmaceuticals Ireland Limited on March 2, 2023. The trademark is classified under Class 10 (Medical Apparatus). The application is currently registered and active.

Trademark Classes

Class 10 - Medical Apparatus

Surgical, medical, dental and veterinary apparatus and instruments

Owner Contact Info

Mallinckrodt Pharmaceuticals Ireland Limited (7 trademarks)

College Business & Technology Park
Blanchardstown, Dublin 15 D15 TX2V , IE

Entity Type: 77

Legal Representation

Attorney of Record

Camille M. Miller

6,738 trademarks filed View all →

Correspondence Address

Camille M. Miller Cozen O'Connor

1650 Market Street, Suite 2800

Philadelphia, PA 19103

United States

Trademark Details

Filing Date

March 2, 2023

Registration Date

March 10, 2026

Published for Opposition

November 7, 2023

Goods & Services

Medical apparatus and instruments for use in connection with the administration of gases to patients for medical and therapeutic purposes, namely, medical and therapeutic gas delivery systems comprised primarily of gas cylinders, valves, regulators, flow meters, delivery hoses and apparatus and instruments for setting, measuring and regulating the mixture of medical and therapeutic gases delivered to patients

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Mar 13, 2026 TCCA

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

Mar 13, 2026 ECDR

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Mar 13, 2026 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Mar 13, 2026 REAP

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Mar 13, 2026 CHAN

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Mar 13, 2026 COAR

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Mar 10, 2026 NRCC

REGISTERED-PRINCIPAL REGISTER

Mar 10, 2026 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Feb 18, 2026 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Feb 18, 2026 CNPR

STATEMENT OF USE PROCESSING COMPLETE

Feb 13, 2026 SUPC

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Feb 13, 2026 AITU

ASSIGNED TO EXAMINER

Jan 24, 2026 DOCK

USE AMENDMENT FILED

Aug 8, 2025 IUAF

TEAS STATEMENT OF USE RECEIVED

Aug 8, 2025 EISU

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jun 28, 2025 EXRA

SOU EXTENSION 3 GRANTED

Jun 27, 2025 EX3G

SOU EXTENSION 3 FILED

Jun 27, 2025 EXT3

SOU TEAS EXTENSION RECEIVED

Jun 27, 2025 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 3, 2025 EXRA

SOU EXTENSION 2 GRANTED

Jan 1, 2025 EX2G

SOU EXTENSION 2 FILED

Dec 31, 2024 EXT2

SOU TEAS EXTENSION RECEIVED

Dec 31, 2024 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jul 1, 2024 EXRA

SOU EXTENSION 1 GRANTED

Jul 1, 2024 EX1G

SOU EXTENSION 1 FILED

Jul 1, 2024 EXT1

SOU TEAS EXTENSION RECEIVED

Jul 1, 2024 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jan 2, 2024 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Nov 7, 2023 NPUB

PUBLISHED FOR OPPOSITION

Nov 7, 2023 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Oct 18, 2023 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Oct 4, 2023 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Oct 3, 2023 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Oct 2, 2023 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Oct 2, 2023 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jul 14, 2023 GNRN

NON-FINAL ACTION E-MAILED

Jul 14, 2023 GNRT

NON-FINAL ACTION WRITTEN

Jul 14, 2023 CNRT

ASSIGNED TO EXAMINER

Jul 13, 2023 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Mar 22, 2023 NWOS

NEW APPLICATION ENTERED

Mar 6, 2023 NWAP

Related Trademarks

More from this Owner

KEENOVA CARES

KEENOVA

KEENOVA CARES

KEENOVA CARES COMPASSION. ACCESS. REIMBURSEMENT. EMPOWERMENT. SUPPORT.

KEENOVA THERAPEUTICS

More in Same Class

QIVI LITE